Panel Discussion: Injectable Packaging 4.0: Securing quality, stability and compliance

Moderator:
• Mr Sandeep Amritkar, Assistant Director, Lupin Pharmaceuticals

Panelists in this video:
• Mr Vidwans Rajendra Ramachandra, Senior Consultant – GMP, QA, in Sterile, Non-sterile dosage forms, GAP
• Ms Leena Padala, Head-Packaging Development & OpEx- R&D, Eugia Pharma Specialities
• Dr Bhaskar Chauhan, Leading R&D and Quality Management, Puniska Injectable
• Mr Rajesh Kumar Chopra, President-Operations, ICHOR Biologics
• Mr Kiran Deshmukh, Site Head-Sterile Injectables, Lupin Pharmaceuticals
• Mr Tridip Mazumder, Head Packaging Development- Sterile, Dr Reddy’s Laboratories
• Mr Prasadha Rao Lysetti, VP – Operational Excellence, Sterile Injectable Operations, Rising Pharmaceuticals

Key Highlights:
[1] Injectable packaging plays a critical role in maintaining product stability, sterility, and safety throughout its lifecycle

[2] The selection of the right material and systems for injectables must consider drug compatibility, leachables, and extractables to avoid stability risks.

[3] To expand access to self-injection devices, they must be designed for cost-effective manufacturing. This would ensure they are affordable, user-friendly and accessible

[4] Injectable packaging requires close collaboration across functions, be it partner selection, material and label choices, visual inspection, track & trace, and cold chain to ensure product quality, safety and compliance

[5] Advanced systems like robotic isolators and real-time particle monitoring, automated machines are driving precision, sterility and efficiency in injectable packaging

[6] Self-administered devices can pose risks without proper training. Support systems, education and guidance can ensure safe, accurate use, enhancing patient centricity and adherence.